Integration in action
Your health concerns and medication needs don’t fall neatly under pharmacy or medical. We take a deeply integrated, channel independent, holistic approach to designing products that manage cost and provide smarter care that’s right for each person.
TRUSTED PARTNERSHIP
Building next-generation solutions for — and with — our clients
We share our clients’ goals, which is why we’re dedicated to offering a wide array of leading-edge solutions that unlock the potential of integrated drug management and help deliver better, more affordable outcomes.
Our solutions
![](https://www.primetherapeutics.com/wp-content/uploads/2023/09/00-B-Managing-Specialty_540x440.png)
Managing specialty
Specialty drugs are changing lives for the better, but they are also costly for the plans and members who pay for them. We offer a new approach that can help drive savings and better control.
Lowering drug costs
Effective drug lists are one of the best ways to ensure the lowest total cost of care. We curate the right drugs while removing those that are medically unnecessary or have clinically appropriate, cost-effective alternatives.
![](https://www.primetherapeutics.com/wp-content/uploads/2023/09/00-C-Lowering-Drug-Costs_540x440.png)
![](https://www.primetherapeutics.com/wp-content/uploads/2023/09/00-D-Optimizing-Drug-Access_540x440.png)
Optimizing drug access
Channel optimization means our clients can choose any solutions that meet their needs, and members can get their medicine the way they want it — and at the lowest cost.
Improving medication adherence
We ensure members have the medication they need when they need it, helping to keep people healthy while improving safety, decreasing waste and delivering a seamless experience.
![](https://www.primetherapeutics.com/wp-content/uploads/2023/09/00-E-Improving-Med-Adherence_540x440.png)
Explore our latest work
Perspectives
July 25, 2024
Quarterly Drug Pipeline: July 2024
Clinical insights and competitive intelligence on anticipated drugs in development
Perspectives
July 22, 2024
Oncology Insights: 2024 ASCO Annual Meeting key findings
Findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting will likely lead to clinical practice changes and U.S. Food and Drug Administration (FDA) drug approvals or expansions
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Each Blue Cross® and/or Blue Shield® plan is an independent licensee of the Blue Cross and Blue Shield Association.